REFRACTORY COLORECTAL CARCINOMA
Clinical trials for REFRACTORY COLORECTAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY COLORECTAL CARCINOMA trials appear
Sign up with your email to follow new studies for REFRACTORY COLORECTAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo targets Hard-to-Treat cancers in early trial
Disease control OngoingThis early-phase study tests a new drug (M6620) combined with a standard chemotherapy (irinotecan) in adults with advanced solid tumors that have spread or can't be removed. The main goal is to find the safest dose and check for side effects. About 66 people with cancers like col…
Matched conditions: REFRACTORY COLORECTAL CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 15, 2026 19:09 UTC
-
Blood test may help personalize colorectal cancer therapy
Disease control OngoingThis study tests whether a blood test that detects tumor DNA can help doctors choose the right treatment for people with advanced colorectal cancer that has not responded to prior therapies. About 100 participants will receive either standard care or treatment guided by the blood…
Matched conditions: REFRACTORY COLORECTAL CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 12, 2026 12:05 UTC